Fluticasone Furoate recalls
The FDA has published 3 recalls involving Fluticasone Furoate since 2021. The latest was reported on 2 Jun 2021. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why fluticasone furoate is recalled
Companies
Brands
By year
All fluticasone furoate recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Arnuity Ellipta (fluticasone furoate inhalation powder) recalledArnuity Ellipta | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Trelegy Ellipta (fluticasone furoate, umeclidinium recalledTrelegy Ellipta | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Trelegy Ellipta (fluticasone Furoate recalled by Cardinal HealthTrelegy Ellipta | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
Should you stop taking Fluticasone Furoate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.